Brain atrophy in relapsing multiple sclerosis: Relationship to relapses, EDSS, and treatment with interferon βla

Multiple Sclerosis

Volumn 6, Issue 6, 2000, Pages 365-372

  Rudick, Richard A ^a   Fisher, Elizabeth ^a   Lee, Jar Chi ^a   Duda, Jeffrey T ^a   Simon, Jack ^b  

^a LERNER RESEARCH INSTITUTE   (United States)

^b UNIVERSITY OF COLORADO   (United States)

Author keywords

Brain atrophy; Interferon beta; Magnetic resonance imaging; Multiple sclerosis

Indexed keywords

BETA1A INTERFERON; CORTICOSTEROID; METHYLPREDNISOLONE;

ADULT; ARTICLE; BRAIN ATROPHY; BRAIN SIZE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE COURSE; DISEASE MARKER; DRUG EFFECT; HUMAN; MAJOR CLINICAL STUDY; MULTIPLE SCLEROSIS; NUCLEAR MAGNETIC RESONANCE IMAGING; PARENCHYMA; PHYSICAL DISABILITY; RECURRENCE RISK; RELAPSE; SCORING SYSTEM; STATISTICAL PARAMETERS; TREATMENT OUTCOME;

ADJUVANTS, IMMUNOLOGIC; ADULT; ATROPHY; BRAIN; CLINICAL TRIALS, PHASE III; COHORT STUDIES; DISABILITY EVALUATION; FOLLOW-UP STUDIES; HUMANS; INTERFERON-BETA; MAGNETIC RESONANCE IMAGING; MULTICENTER STUDIES; MULTIPLE SCLEROSIS, RELAPSING-REMITTING; PROSPECTIVE STUDIES; RANDOMIZED CONTROLLED TRIALS; TREATMENT OUTCOME;

EID: 0034487603     PISSN: 13524585     EISSN: None     Source Type: Journal    
DOI: 10.1191/135245800701566322     Document Type: Article

References (26)

1. Axonal pathology in multiple sclerosis: Relationship to neurologic disability
2. Axonal transection in the lesions of multiple sclerosis
3. Use of proton magnetic resonance spectroscopy for monitoring disease progression in multiple sclerosis
4. A longitudinal study of brain atrophy in relapsing multiple sclerosis. The Multiple Sclerosis Collaborative Research Group (MSCRG)
5. Selecting relapsing remitting multiple sclerosis patients for treatment: The case for early treatment
6. Interferon beta-1b is effective in relapsing-remitting multiple sclerosis. I. Clinical results of a multicenter, randomized, double-blind, placebo-controlled trial
7. Interferon beta-1b is effective in relapsing-remitting multiple sclerosis. II. MRI analysis results of a multicenter, randmomized, double-blind, placebo-controlled trial
8. Intramuscular interferon beta-1a for disease progression in relapsing multiple sclerosis. The Multiple Sclerosis Collaborative Research Group (MSCRG)
9. Randomised double-blind placebo-controlled study of interferon beta-1a in relapsing/remitting multiple sclerosis
10. A phase III trial of intramuscular recombinant beta interferon as treatment for exacerbating-remitting sclerosis: Design and conduct of study and baseline characteristics of patients
11. Knowledge-based 3D segmentation of MR images for quantitative MS lesion tracking
12. Use of the brain parenchymal fraction to measure whole brain atrophy in relapsing remitting MS
13. Properties of the novel proinflammatory supergene 'intercrine' cytokine family
14. Contrast-enhanced MR imaging in the evaluation of treatment response and prediction of outcome in multiple sclerosis
15. MRI studies of multiple sclerosis: Implications for the natural history of the disease and for monitoring effectiveness of experimental therapies
16. Using gadolinium-enhanced magnetic resonance imaging lesions to monitor disease activity in multiple sclerosis
17. Quantitative brain MRI lesion load predicts the course of clinically isolated syndromes suggestive of multiple sclerosis
18. The prognostic value of brain MRI in clinically isolated syndromes of the CNS. A 10-year follow-up
19. Quantitative MRI in patients with clinically isolated syndromes suggestive of demyelination
20. A longitudinal magnetic resonance imaging study of the cervical cord in multiple sclerosis
21. Progressive cerebral atrophy in multiple sclerosis. A serial MRI study
22. Spinal cord atrophy and disability in multiple sclerosis: A new reproducible and sensitive MRI method with potential to monitor disease progression
23. Quantitative determination of MS-induced corpus callosum atrophy in vivo using MR imaging
24. The role of oligodendroglia and astroglia in Wallerian degeneration of the optic nerve
25. Interleukin-1-like activity in rat brain: Sources, targets, and effect of injury
26. Magnetic resonance studies of intramuscular interferon beta-1a for relapsing multiple sclerosis. The Multiple Sclerosis Collaborative Research Group